US Patent 10329302 Bicyclic-fused heteroaryl or aryl compounds

Patent 10329302 was granted and assigned to Pfizer Limited on June, 2019 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

June 25, 2019

Patent Application Number

15862691

Date Filed

January 5, 2018

Patent Citations Received

Patent Primary Examiner

Patent abstract

Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia,

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 10329302 Bicyclic-fused heteroaryl or aryl compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.